Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Harvard Bioscience, Inc. - Common Stock (NQ:HBIO)

5.000 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, May 18, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Harvard Bioscience, Inc. - Common Stock

< Previous 1 2 3 4 5 6 Next >
News headline image
Traders are paying attention to the gapping stocks in Tuesday's session. ↗
Let's have a look at the gap up and gap down stocks in today's session. 
Via Chartmill
News headline image
Harvard Bioscience, Inc. to Participate in Two Investor Conferences in March 2025
From Harvard Bioscience, Inc.
Via GlobeNewswire
News headline image
Harvard Bioscience Announces Fourth Quarter and Full-Year 2024 Financial Results
From Harvard Bioscience, Inc.
Via GlobeNewswire
News headline image
A Preview Of Harvard Bioscience's Earnings ↗
 
Via Benzinga
News headline image
Earnings Scheduled For March 12, 2025 ↗
 
Via Benzinga
News headline image
Harvard Bioscience to Showcase Latest Solutions for Preclinical and Organoid Applications at Society of Toxicology Meeting
Advanced platforms for CROs, pharmaceutical and biotech companies seeking to enhance productivity 
From Harvard Bioscience, Inc.
Via GlobeNewswire
News headline image
Harvard Bioscience Schedules Fourth Quarter 2024 Earnings Conference Call for March 12, 2025 at 8:00 AM ET
From Harvard Bioscience, Inc.
Via GlobeNewswire
News headline image
12 Health Care Stocks Moving In Thursday's Intraday Session ↗
 
Via Benzinga
News headline image
Harvard Bioscience Announces Third Quarter 2024 Financial Results
From Harvard Bioscience, Inc.
Via GlobeNewswire
News headline image
Harvard Bioscience Schedules Third Quarter 2024 Earnings Conference Call for November 7, 2024 at 8:00 AM ET
From Harvard Bioscience, Inc.
Via GlobeNewswire
News headline image
Harvard Bioscience to Showcase Innovative Technologies at Society for Neuroscience (SfN) Annual Meeting 2024
New products complement an already extensive range of products enabling fundamental advancements in neuroscience research 
From Harvard Bioscience, Inc.
Via GlobeNewswire
News headline image
Harvard Bioscience to Showcase Latest Solutions for Preclinical and Organoid Applications at Safety Pharmacology Society Annual Meeting
Solutions for CROs, pharma and biotechs streamline testing and enable fundamental advancements in preclinical and organoid focused therapy development 
From Harvard Bioscience, Inc.
Via GlobeNewswire
News headline image
HBIO Stock Earnings: Harvard Bioscience Misses Revenue for Q2 2024 ↗
HBIO stock results show that Harvard Bioscience missed on revenue for the second quarter of 2024. 
Via InvestorPlace
News headline image
Harvard Bioscience Announces Second Quarter 2024 Financial Results
From Harvard Bioscience, Inc.
Via GlobeNewswire
News headline image
Harvard Bioscience Schedules Second Quarter 2024 Earnings Conference Call for August 8, 2024 at 10:00 AM ET
From Harvard Bioscience, Inc.
Via GlobeNewswire
News headline image
Holley And 2 Other Stocks Under $5 Insiders Are Buying ↗
 
Via Benzinga
News headline image
FlexShopper And 3 Other Stocks Under $5 Insiders Are Buying ↗
 
Via Benzinga
News headline image
Harvard Bioscience, Inc. to Present and Host One-on-One Meetings at the 14th Annual East Coast IDEAS Conference on June 12, 2024
From Harvard Bioscience, Inc.
Via GlobeNewswire
News headline image
Harvard Bioscience, Inc. to Present at the Jefferies Global Healthcare Conference on June 5, 2024
From Harvard Bioscience, Inc.
Via GlobeNewswire
News headline image
Harvard Bioscience, Inc. to Participate in the Benchmark Healthcare House Call Virtual Conference
From Harvard Bioscience, Inc.
Via GlobeNewswire
News headline image
HBIO Stock Earnings: Harvard Bioscience Meets EPS, Misses Revenue for Q1 2024 ↗
HBIO stock results show that Harvard Bioscience met analyst estimates for earnings per share but missed on revenue for the first quarter of 2024. 
Via InvestorPlace
News headline image
Harvard Bioscience Announces First Quarter 2024 Financial Results
Strong gross margin performance and focus on efficiency to support ongoing investments in growth 
From Harvard Bioscience, Inc.
Via GlobeNewswire
News headline image
Harvard Bioscience Schedules First Quarter 2024 Earnings Conference Call for May 7, 2024 at 8:00 AM ET
From Harvard Bioscience, Inc.
Via GlobeNewswire
News headline image
Harvard Bioscience Announces Action to Improve Operational Efficiency and Support Ongoing Investments in Growth
From Harvard Bioscience, Inc.
Via GlobeNewswire
News headline image
Harvard Bioscience, Inc. to Participate in March 2024 Investor Conferences: Sidoti’s Small Cap Conference and KeyBanc’s Life Sciences & MedTech Conference
From Harvard Bioscience, Inc.
Via GlobeNewswire
News headline image
HBIO Stock Earnings: Harvard Bioscience Misses EPS, Misses Revenue for Q4 2023 ↗
HBIO stock results show that Harvard Bioscience missed analyst estimates for earnings per share and missed on revenue for the fourth quarter of 2023. 
Via InvestorPlace
News headline image
Harvard Bioscience Announces Fourth Quarter 2023 Financial Results
From Harvard Bioscience, Inc.
Via GlobeNewswire
News headline image
Harvard Bioscience to Showcase Latest Solutions for Preclinical and Organoid Applications at Society of Toxicology Meeting
Solutions for CROs, pharma and biotechs improve throughput and efficiency and enable future advancements in data analytics 
From Harvard Bioscience, Inc.
Via GlobeNewswire
News headline image
Harvard Bioscience Schedules Fourth Quarter 2023 Earnings Conference Call for March 7, 2024 at 8:00 AM ET
From Harvard Bioscience, Inc.
Via GlobeNewswire
News headline image
Earnings Scheduled For March 7, 2024 ↗
Companies Reporting Before The Bell • CI&T (NYSE:CINT) is estimated to report quarterly earnings at $0.06 per share on revenue of $106.08 million. 
Via Benzinga
< Previous 1 2 3 4 5 6 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.